Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Silybum marianum (Silybin).
Silybin functions as a hepatoprotective agent by modulating the NF-κB signaling pathway, stimulating ribosomal RNA polymerase I to accelerate protein synthesis, and acting as a free radical scavenger to mitigate lipid peroxidation in hepatic membranes.
31553
482.4 g/mol
2.4
(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Silybum marianum (Silybin) across standard consumer modalities.
The primary constraint is the low aqueous solubility and poor intestinal permeability of the flavonolignan complex, necessitating high-volume excipients or micronization.
The hydrophobic nature of silymarin can cause phase separation and gritty texture within the pectin matrix, often requiring emulsifiers that affect setting time.
The high therapeutic dose required for hepatoprotection typically exceeds the 20-30mg payload limit of standard thin-film polymer matrices.
Ready to launch a product featuring Silybum marianum (Silybin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Silybum marianum (Silybin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Silybum marianum (Silybin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation